Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women 10/04/2007 INTERVENTIONAL unchanged 6,901.85 0 Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer 11/30/2007 INTERVENTIONAL unchanged 6,844.85 0 Pompe Pregnancy Sub-Registry 12/04/2007 OBSERVATIONAL unchanged 6,840.85 0 Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing 12/14/2007 OBSERVATIONAL unchanged 6,830.85 0 Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients 12/28/2007 OBSERVATIONAL unchanged 6,816.85 0 Efficacy and Safety of 500mg of Fulvestrant 01/03/2008 INTERVENTIONAL unchanged 6,810.85 0 Estrogen, Diet, Genetics and Endometrial Cancer 01/08/2008 OBSERVATIONAL unchanged 6,805.85 0 Menstrual Cycle Maintenance and Quality of Life: A Prospective Study 01/10/2008 OBSERVATIONAL unchanged 6,803.85 0 Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships 01/28/2008 INTERVENTIONAL unchanged 6,785.85 0 Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer 02/15/2008 INTERVENTIONAL unchanged 6,767.85 0 Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer 11/11/2008 INTERVENTIONAL unchanged 6,497.85 0 Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer 11/14/2008 OBSERVATIONAL unchanged 6,494.85 0 Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients 11/25/2008 INTERVENTIONAL unchanged 6,483.85 0 Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease 11/25/2008 INTERVENTIONAL unchanged 6,483.85 0 Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood 11/26/2008 INTERVENTIONAL unchanged 6,482.85 0 Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations 01/15/2009 OBSERVATIONAL unchanged 6,432.85 0 Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. 01/21/2009 OBSERVATIONAL unchanged 6,426.85 0 Women's Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction 01/30/2009 OBSERVATIONAL unchanged 6,417.85 0 Vitamin D Supplementation During Pregnancy for Prevention of Asthma in Childhood 03/06/2009 INTERVENTIONAL unchanged 6,382.85 0 Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls 03/23/2009 OBSERVATIONAL unchanged 6,365.85 0 Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer 05/12/2009 OBSERVATIONAL unchanged 6,315.85 0 Collecting and Storing Tissue Samples From Women With or Without Breast Cancer 05/12/2009 OBSERVATIONAL unchanged 6,315.85 0 Cervical Cancer Detection Using Optical Spectroscopy 05/13/2009 INTERVENTIONAL unchanged 6,314.85 0 Study of Radiation Exposure and Bilateral Breast Cancer 05/18/2009 OBSERVATIONAL unchanged 6,309.85 0 A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease 05/20/2009 OBSERVATIONAL unchanged 6,307.85 0 Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS) 05/25/2009 INTERVENTIONAL unchanged 6,302.85 0 Radiation Therapy in Treating Women With Early Stage Breast Cancer 05/29/2009 INTERVENTIONAL unchanged 6,298.85 0 Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism 06/26/2009 INTERVENTIONAL unchanged 6,270.85 0 Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients 06/26/2009 INTERVENTIONAL unchanged 6,270.85 0 Intra-Pelvic Organ Motion for Cervix Cancer Patient Using Imaging 08/12/2009 OBSERVATIONAL unchanged 6,223.85 0 Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer 09/15/2009 INTERVENTIONAL unchanged 6,189.85 0 Lymphedema Following Hand/Wrist Surgery in Women Post Axillary Node Dissection 09/25/2009 INTERVENTIONAL unchanged 6,179.85 0 A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer 10/05/2009 OBSERVATIONAL unchanged 6,169.85 0 Study of Changes in Skeletal Muscle After Caloric Restriction 10/12/2009 OBSERVATIONAL unchanged 6,162.85 0 Extension Study of Lapatinib Plus Herceptin With or Without Endocrine Therapy 10/22/2009 INTERVENTIONAL unchanged 6,152.85 0 Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer 10/23/2009 OBSERVATIONAL unchanged 6,151.85 0 Motivational Interviewing for Physical Activity 11/06/2009 INTERVENTIONAL unchanged 6,137.85 0 Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples 12/17/2009 OBSERVATIONAL unchanged 6,096.85 0 Magnetic Resonance Imaging of Breast Cancer 12/18/2009 INTERVENTIONAL unchanged 6,095.85 0 Colposcopy Versus HPV Testing to Identify Persistent Cervical Precancers 01/20/2010 INTERVENTIONAL unchanged 6,062.85 0 Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4) 02/08/2010 INTERVENTIONAL unchanged 6,043.85 0 Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer 02/12/2010 INTERVENTIONAL unchanged 6,039.85 0 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer 03/05/2010 INTERVENTIONAL unchanged 6,018.85 0 Extending the National Health Service (NHS) Breast Screening Age Range 03/05/2010 INTERVENTIONAL unchanged 6,018.85 0 Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer 03/05/2010 INTERVENTIONAL unchanged 6,018.85 0 Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer 03/26/2010 INTERVENTIONAL unchanged 5,997.85 0 Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer 05/05/2010 INTERVENTIONAL unchanged 5,957.85 0 Ethnic Differences in the Impact of Breast Cancer on Employment Status, Financial Situation, and Quality of Life 05/31/2010 OBSERVATIONAL unchanged 5,931.85 0 Excision Followed by Radiofrequency Ablation for Breast Cancer 06/29/2010 INTERVENTIONAL unchanged 5,902.85 0 Teriparatide (PTH) and Bone Strength in Postmenopausal Women 07/01/2010 OBSERVATIONAL unchanged 5,900.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology